Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

Published: 28 February 2025| Version 1 | DOI: 10.17632/d9ngfbjxp3.1
Contributors:
,
,
,
,

Description

Supplemental figure 1 relative survival by year of diagnosis and extent of MCC at presentation. Supplemental figure 2 24-month overall survival by year of diagnosis and extent of Merkel cell carcinoma at presentation.

Files

Institutions

University of Washington, Swedish Cancer Institute, Fred Hutchinson Cancer Research Center, Washington State University

Categories

Epidemiology, Oncology, Merkel Cell Carcinoma, Survival Analysis, Immunotherapy, Database

Funders

Licence